Combined Use of INSM1 and Synaptophysin Is the Most Sensitive and Specific Panel to Detect Neuroendocrine Neoplasms in the Digestive Tract.
暂无分享,去创建一个
[1] S. Mukhopadhyay,et al. INSM1 Is a Highly Specific Marker of Neuroendocrine Differentiation in Primary Neoplasms of the Gastrointestinal Tract, Appendix, and Pancreas. , 2020, American journal of clinical pathology.
[2] D. Chatterjee,et al. Insulinoma‐associated protein 1 expression in primary and metastatic neuroendocrine neoplasms of the gastrointestinal and pancreaticobiliary tracts , 2019, Histopathology.
[3] Takaaki Ito,et al. Insulinoma‐associated protein 1 expression in pancreatic neuroendocrine tumours in endoscopic ultrasound‐guided fine‐needle aspiration cytology: An analysis of 14 patients , 2018, Cytopathology : official journal of the British Society for Clinical Cytology.
[4] Seung‐Mo Hong,et al. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts. , 2016, Archives of pathology & laboratory medicine.
[5] M. Washington,et al. Pathology Reporting of Neuroendocrine Tumors: Application of the Delphic Consensus Process to the Development of a Minimum Pathology Data Set , 2010, The American journal of surgical pathology.